Liver-specific transgenic expression of the transcriptionally active form of SREBP1c exacerbates hepatic steatosis and diet-induced weight gain30,31, whereas inhibition of this pathway elicits beneficial metabolic effects32,33. This evidence concerns the gene SREBF1 and fatty liver disease.